Chronic pancreatitis
Jörg Kleeff(Technical University of Munich), John P. Neoptolemos(University of Liverpool), David C. Whitcomb(University of Pittsburgh), Tooru Shimosegawa(Tohoku University), Asbjørn Mohr Drewes(Aalborg University Hospital), Iréne Esposito(Heinrich Heine University Düsseldorf), Fatih Akisik(Indiana University School of Medicine), Thomas M. Gress(Philipps University of Marburg), J. Enrique Domínguez‐Muñoz(Queen Mary University of London), Vinciane Rebours(Hôpital Beaujon), Markus M. Lerch(Universitätsmedizin Greifswald), Julia Mayerle(Ludwig-Maximilians-Universität München)
Cited by 447
Related Papers
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k
Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
|Nature Genetics|1996|1.6k
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
|JAMA|2010|1.4k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
Chronic pancreatitis: Diagnosis, classification, and new genetic developments
|Gastroenterology|2001|1.2k